AllianceRx Walgreens Prime announces research results
ORLANDO, Fla. — AllianceRx Walgreens Prime and Walgreens recently announced results from separate research studies exploring the impact of adherence on hospitalizations and medical costs as they related to cystic fibrosis (CF) and ulcerative colitis (UC)/Crohn’s disease, respectively. Researchers wanted to better understand the effect of adherence on patient outcomes and well-being. Findings from both